MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species.
Vera-Puente O, Rodriguez-Antolin C, Salgado-Figueroa A, Michalska P, Pernia O, Reid BM, Rosas R, Garcia-Guede A, SacristÁn S, Jimenez J, Esteban-Rodriguez I, Martin ME, Sellers TA, León R, Gonzalez VM, De Castro J, Ibanez de Caceres I.
Vera-Puente O, et al. Among authors: martin me.
Transl Res. 2018 Oct;200:1-17. doi: 10.1016/j.trsl.2018.06.005. Epub 2018 Jun 30.
Transl Res. 2018.
PMID: 30053382
Free PMC article.